SEARCH

SEARCH BY CITATION

REFERENCES

  • American College of Obstetrics and Gynecology. 2006. Management of alloimmunization during pregnancy. ACOG Practice Bulletin #75. Obstet Gynecol 108: 457464.
  • Akolekar R, Farkas DH, VanAgtmael AL, Bombard AT, Nicolaides KH. 2010. Fetal sex determination using circulating cell-free fetal DNA (ccffDNA) at 11 to 13 weeks of gestation. Prenat Diagn 30: 918923.
  • Al-Yatama MK, Mustafa AS, Al-Kandari FM, et al. 2007. Polymerase-chain-reaction-based detection of fetal rhesus D and Y-chromosome-specific DNA in the whole blood of pregnant women during different trimesters of pregnancy. Med Princ Pract 16: 327332.
  • Blanco-Arias P, Sargent CA, Affara NA. 2002. The human-specific Yp11.2/Xq21.3 homology block encodes a potentially functional testis-specific TGIF-like retroposon. Mammalian Genome 13: 463468.
  • Brambati B, Guercilena S, Bonacchi I, Oldrini A, Lanzani A, Piceni L. 1986. Feto-maternal transfusion after chorionic villus sampling: clinical implications. Hum Reprod 1: 3740.
  • Brojer E, Zupanska B, Guz K, Orziñska A, Kaliñska A. 2005. Noninvasive determination of fetal RHD status by examination of cell-free DNA in maternal plasma. Transfusion 45: 14731480.
  • Chim SS, Tong YK, Chiu RW, et al. 2005. Detection of placental epigenetic signature of maspin gene in maternal plasma. Proc Nat Acad Sci 102: 1475314758.
  • Costa JM, Giovangrandi Y, Ernault P, et al. 2002. Fetal RHD genotyping in maternal serum during the first trimester of pregnancy. Br J Haematol 119: 255260.
  • Daniels G, Finning K, Martin P, Massey E. 2009. Noninvasive prenatal diagnosis of fetal blood group phenotypes: current practice and future prospects. Prenat Diagn 29: 101107.
  • Ding C. 2008. Maldi-TOF mass spectrometry for analyzing cell-free fetal DNA in maternal plasma. Methods Mol Biol 444: 253267.
  • Ding C, Cantor CR. 2003. A high-throughput gene expression analysis technique using competitive PCR and matrix-assisted laser desorption ionization time-of-flight MS. Proc Natl Acad Sci USA 100: 30593064.
  • Farkas DH, Miltgen NE, Stoerker J, et al. 2010. The suitability of matrix assisted laser desorption/ionization—time of flight mass spectrometry in a laboratory developed test using cystic fibrosis carrier screening as a model. J Mol Diagn 12: 611619.
  • Finning K, Martin P, Summers J, Massey E, Poole G, Daniels G. 2008. Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility study. BMJ 336: 816818.
  • Finning KM, Martin PG, Soothill PW, Avent ND. 2002. Prediction of fetal D status from maternal plasma: introduction of a new noninvasive fetal RHD genotyping service. Transfusion 42: 10791085.
  • Freeman K, Osipenko L, Clay D, Hyde J, Szczepura A 2006. Initial Report on NIPD Evidence Base: Prepared by Socio-Economic Group, University of Warwick for Workpackage 6, SAFE Network of Excellence, Special Noninvasive Advances in Fetal and Neonatal Evaluation (SAFE) CONTRACT No LSHB-CT-2004-503243.
  • Geifman-Holtzman O, Grotegut CA, Gaughan JP. 2006. Diagnostic accuracy of noninvasive fetal Rh genotyping from maternal blood—a meta-analysis. Am J Obstet Gynecol 195: 11631173.
  • Grill S, Banzola I, Li Y, et al. 2009. High throughput noninvasive determination of foetal Rhesus D status using automated extraction of cellfree foetal DNA in maternal plasma and mass spectrometry. Arch Gynecol Obstet 279: 533537.
  • Jennings L, Van Deerlin VM, Gulley ML, College of American Pathologists Molecular Pathology Resource Committee. 2009. Recommended principles and practices for validating clinical molecular pathology tests. Arch Pathol Lab Med 133: 743755.
  • Jurinke C, Oeth P, van den Boom D. 2004. MALDI-TOF mass spectrometry: a versatile tool for high-performance DNA analysis. Mol Biotechnol 26: 147164.
  • Legler TJ, Muller SP, Haverkamp A, Grill S, Hahn S. 2009. Prenatal RhD testing: a review of studies published from 2006 to 2008. Transfus Med Hemother 36: 189198.
  • Li Y, Holzgreve W, Kiefer V, Hahn S. 2006. Maldi-tof mass spectrometry compared with real-time PCR for detection of fetal cell-free DNA in maternal plasma. Clin Chem 52: 23112312.
  • Lo YM, Hjelm NM, Fidler C, et al. 1998. Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. N Engl J Med 339: 17341738.
  • Machado IN, Castilho L, Pellegrino J Jr, Barini R. 2006. Fetal RHD genotyping from maternal plasma in a population with a highly diverse ethnic background. Rev Assoc Med Bras 52: 232235.
  • Minon JM, Gerard C, Senterre JM, Schaaps JP, Foidart JM. 2008. Routine fetal RHD genotyping with maternal plasma: a four-year experience in Belgium. Transfusion 48: 373381.
  • Oeth P, del Mistro G, Marnellos G, Shi T, van den Boom, D. 2009. Qualitative and quantitative genotyping using single base primer extension coupled with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MassARRAY®). Methods Mol Biol 578: 307343.
  • Oeth P, Ehrich M, Lee M. 2008. Nucleic acid-based tests for RHD typing, gender determination, and nucleic acid quantification; United States Patent Application Publication; Pub. No.: US 2008/0299562; Pub. Date: December 4, 2008; Filed: February 7, 2008. Inventors: Paul A. Oeth, San Diego, CA (US); Mathias Ehrich, San Diego, CA (US); Min S. Lee, San Diego, CA (US).
  • Pertl B, Sekizawa A, Samura O, Orescovic I, Rahaim PT, Bianchi DW. 2000. Detection of male and female fetal DNA in maternal plasma by multiplex fluorescent polymerase chain reaction amplification of short tandem repeats. Hum Genet 106: 4549.
  • Randen I, Hauge R, Kjeldsen-Kragh J, Fagerhol MK. 2003. Prenatal genotyping of RHD and SRY using maternal blood. Vox Sang 85: 300306.
  • Tabor A, Bang J, Nørgaard-Pedersen B. 1987. Feto-maternal haemorrhage associated with genetic amniocentesis: results of a randomized trial. Br J Obstet Gynaecol 94: 528534.
  • Tang NL, Leung TN, Zhang J, Lau TK, Lo YM. 1999. Detection of feta-derived paternally inherited X-chromosome polymorphisms in maternal plasma. Clin Chem 45: 20332035.
  • Thongnoppakhun W, Jiemsup S, Yongkiettrakul S, et al. 2009. Simple, efficient, and cost-effective multiplex genotyping with matrix assisted laser desorption/ionization time-of-flight mass spectrometry of homoglobin beta gene mutations. J Mol Diagn 11: 334346.
  • Tynan JA, Angkachatchai V, Ehrich M, Paladino T, van den Boom D, Oeth P. 2010. Mulitiplexed analysis of circulating cell-free fetal nucleic acids for noninvasive prenatal diagnostic RHD testing. Am J Obstet Gynecol 204(3): 251.e1e6.
  • Van den Boom D, Oeth P, Ehrich M, et al. 2006. “Fetal Identifiers” as a universal approach for noninvasive prenatal diagnostics. Am J Obstet Gynecol 195: S714, #570.
  • Van der Schoot CE, Hahn S, Chitty LS. 2008. Non-invasive prenatal diagnosis and determination of fetal Rh status. Semin Fetal Neonatal Med 13: 6368.
  • Van der Schoot CE, Soussan AA, Koelewijn J, Bonsel G, Paget-Christiaens LG, de Haas M. 2006. Noninvasive antenatal RHD typing. Transfus Clin Biol 13: 5357.
  • Wright CF, Buton H. 2009. The use of cell-free fetal nucleic acids in maternal blood for non-invasive prenatal diagnosis. Human Reproduction Update 15: 139151.
  • Zhang J, Fidler C, Murphy MF, et al. 2000. Determination of fetal RhD status by maternal plasma DNA analysis. Ann N Y Acad Sci 906: 153155.
  • Zhu B, Sun Q-W, Lu Y-C, Sun M-M, Wang L-J, Huang X-H. 2005. Prenatal fetal sex diagnosis by detecting amelogenin gene in maternal plasma. Prenat Diagn 25: 577581.